The New York Stock Exchange and Nasdaq Inc. on Monday accused a senior regulator who supervises them of having ethical conflicts, raising the ante in a battle with Washington over how the companies sell market data.
The feud stems from a regulatory decision last year on data fees that could crimp exchanges’ profits from selling products that display current market prices and trading interest. The exchanges have appealed the Securities and Exchange Commission’s move to the U.S. Court of Appeals for the District of Columbia...
This is going to get interesting.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Daimler's stock drops as diesel scandal cuts profit for Mercedes' parent companyShare's of German automaker Daimler fell almost 4% in Monday trading after the company said Sunday that profits for the second quarter would be hurt by troubles from its Mercedes-Benz brand and downgraded its earnings forecast for the the full year. Diesel is old dirty tech anyway I'll say what you wanted to headline: 'MORONS!!!!' 😇
La source: CNBC - 🏆 12. / 72 Lire la suite »
FedEx is a 'bottom-fishing' stock heading into earnings, technical analyst saysFedEx heads into earnings this week well off its highs, but one technical analyst says the worst could be over for the delivery company. TradingNation The state has entered into the political history of being a country but it is not possible to say that the state can survive and that the state is always charged with the drction of the crisis and the crisis will come espcially pltical prowess so if the stte probe cn stil be plyd
La source: CNBC - 🏆 12. / 72 Lire la suite »
Palatin's stock rockets after FDA OK to market sexual desire disorder treatmentShares of Palatin Technologies Inc. rocketed 27% in very active premarket trading Monday, after a positive Food and Drug Administration decision on AMAG... BringeReprobate
La source: MarketWatch - 🏆 3. / 97 Lire la suite »